Wird geladen...
Rituximab use for refractory anti-HMGCR immune-mediated necrotizing myopathy: A case report
Immunosuppression is the cornerstone therapy for anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) myopathy. Typical immunosuppressants such as corticosteroids, methotrexate, and azathioprine have been used in conjunction with removal of the offending agent, yet the use of rituximab...
Gespeichert in:
| Veröffentlicht in: | Intractable Rare Dis Res |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8122313/ https://ncbi.nlm.nih.gov/pubmed/33996358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2020.03144 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|